VENTILASTIN

This brand name is authorized in Estonia, Finland, France, Germany, Lithuania.

Active ingredients

The drug VENTILASTIN contains one active pharmaceutical ingredient (API):

1	Salbutamol sulfate UNII 021SEF3731 - ALBUTEROL SULFATE
	Salbutamol is a selective β2-agonist providing short-acting (4-6 hour) bronchodilation with a fast onset (within 5 minutes) in reversible airways obstruction. At therapeutic doses it acts on the β2-adrenoceptors of bronchial muscle. Salbutamol is administered for the symptomatic relief of bronchospasm associated with chronic or acute asthma, bronchitis or other obstructive pulmonary diseases.
	Read more about Salbutamol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R03AC02	Salbutamol	R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AC Selective beta-2-adrenoreceptor agonists
Discover more medicines within R03AC02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	01890728, 01890740, 03088194
EE	Ravimiamet	1282766, 1282777, 1282788
FI	Lääkealan turvallisuus- ja kehittämiskeskus	121793
FR	Base de données publique des médicaments	65779001
LT	Valstybinė vaistų kontrolės tarnyba	1024516, 1055987, 1055988, 1055989, 1055990